CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
Genetics Research · 18.04.2023 · 2023 · 1-10
DOI: 10.1155/2023/8586507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, erschienen am 18.04.2023. Verfasst von Senlong Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Zhuji People's Hospital of Zhejiang Province (Zhuji Affiliated Hospital of Shaoxing University), Zhuji 311800…. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cysteine and Glycine Rich Protein 1 (CSRP1) belongs to the cysteine-rich protein family, which contains a unique double-zinc finger motif and is important for development and cellular differentiation. Abnormal expression of CSRP1 was reported within several malignancies such as prostate cancer and acute myeloid leukemia. Here, we explored function of CSRP1 within colon adenocarcinoma (COAD) for the first time.
Methods
The mRNA levels of CSRP1 in COADs were obtained from TCGA datasets. CSRP1 protein expressions in COADs were tested via immunohistochemistry staining. Patients’ prognosis was evaluated using both univariate analysis and multivariate analysis. Two human COAD originated cancer cell lines, Caco-2, and HT-29, were used for cellular experiments including shRNA knockdown, proliferation assay, and migration assay. In vivo model was established using nude mice xenografts to further validate the role of CSRP1 in COAD progression.
Results
The mRNA levels of CSRP1 are elevated in COAD specimens from patients with more advanced tumor stages and higher Carcinoembryonic Antigen (CEA) levels. In addition, higher CSRP1 mRNA level indicates worse COAD prognosis. Consistently, higher CSRP1 protein expression is correlated with worse overall survival according to both univariate and multivariate analysis, indicating that CSRP1 is a new COAD prognostic factor. Furthermore, COAD cells transfected with CSRP1-shRNAs exhibit attenuated proliferation and migration capacities. Finally, growth of xenografts originated from CSRP1-knockdown cells is inhibited comparing to the control ones.
Conclusions
Expression of CSRP1 is positively correlated with COAD progression, which can promote tumor growth and migration. Higher CSRP1 can is a novel independent prognostic factor of COAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Zhuji People's Hospital of Zhejiang Province (Zhuji Affiliated Hospital of Shaoxing University), Zhuji 311800, China.
- Department of General Surgery, Zhuji Chinese Traditional Medical Hospital, Zhuji 311800, China.
- Colorectal Surgery Department, Changzheng Hospital, Shanghai 200003, China.
ORCID-Profile: Canping Ruan
Zitieren
APA
Yu, S., Zhao, H., Meng, H., Shi, S., Cao, S., Bian, T., & Ruan, C. (2023). CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. Genetics Research, 2023, 1-10. https://doi.org/10.1155/2023/8586507
Vancouver
Yu S, Zhao H, Meng H, Shi S, Cao S, Bian T, et al. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis. Genetics Research. 2023;2023:1-10. doi:10.1155/2023/8586507
BibTeX
@article{Yu2023,
author = {Yu, Senlong and Zhao, Haifeng and Meng, Hongjie and Shi, Shengguang and Cao, Shenghui and Bian, Tianhua and Ruan, Canping},
title = {CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis},
journal = {Genetics Research},
year = {2023},
volume = {2023},
pages = {1--10},
doi = {10.1155/2023/8586507}
}
EUVIMED